Understanding the molecular basis underlying the specific functional consequences triggered by Kv7.2 variants, besides shedding light on disease pathophysiology, may also guide patient-tailored therapeutic approaches to be undertaken in patients affected with Kv7.2-related epilepsies. The gene discussed is KCNQ2; the disease is epilepsy.